Archive: August 2017

Frontline Management of Chronic Lymphocytic Leukemia

Richard R. Furman, MD

Supplement 10 How I Treat Chronic Lymphocytic Leukemia: An Expert Perspective on Frontline Management Richard R. Furman, MD Director of the CLL Research Center Weill Cornell […]

Highlights in Aggressive Non-Hodgkin Lymphoma From the 2017 American Society of Clinical Oncology Annual Meeting

Commentary by Frederick L. Locke, MD

Supplement 8 A Review of Selected Presentations From the 2017 American Society of Clinical Oncology Annual Meeting • June 1-5, 2017 • Chicago, Illinois Clinical and […]

Highlights in Ovarian Cancer From the 2017 American Society of Clinical Oncology Annual Meeting

Commentary by Ursula A. Matulonis, MD

A Review of Selected Presentations From the 2017 American Society of Clinical Oncology Annual Meeting • June 1-5, 2017 • Chicago, Illinois Long-Term Benefit of Niraparib Treatment […]

,

The Treatment Path in Hepatocellular Carcinoma

Hashem B. El-Serag, MD, MPH, Andrew X. Zhu, MD, PhD, and Matthew S. Johnson, MD

Supplement 9 Abstract: The treatment approach for hepatocellular carcinoma (HCC) depends on the stage and extent of disease, the severity of the underlying liver disease, and the […]

Back to Archive